BamSEC and AlphaSense Join Forces
Learn More

Kalaris Therapeutics Inc. – Transcripts

NASDAQ: KLRS    
Share price (9/29/26): $2.90    
Market cap (9/29/26): $69.0 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
M&A Revised 11/08/24 AlloVir, Inc., Kalaris Therapeutics, Inc. - M&A Call 11/08/24
CY 2023
Other Revised 09/11/23 AlloVir, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 04:55 PM 09/11/23
Other Revised 06/07/23 AlloVir, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 08:40 AM 05/09/23
Other Revised 02/15/23 AlloVir, Inc. - Special Call 02/15/23
Other Revised 01/10/23 AlloVir, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 02:15 PM 01/10/23
CY 2022
Other Revised 12/14/22 AlloVir, Inc. - Special Call 12/14/22
Other Revised 09/14/22 AlloVir, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-14-2022 12:20 PM 09/14/22
Other Revised 01/10/22 AlloVir, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 04:30 PM 01/10/22